Caplin Point Laboratories Limited (CAPLIPOINT.NS)
INR 2396.95
(0.02%)
INR 2396.95
(0.02%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.61 Billion | 2.71 Billion | 3.36 Billion | 2.65 Billion | 446.77 Million | 834.24 Million |
| Net Income | 4.57 Billion | 4.51 Billion | 3.85 Billion | 3.13 Billion | 2.69 Billion | 2.26 Billion |
| Depreciation & Amortization | 534.4 Million | 449.9 Million | 469 Million | 369.71 Million | 316.19 Million | 234.25 Million |
| Deferred income taxes | - | - | - | -747.71 Million | -591.02 Million | -486.7 Million |
| Stock-based compensation | 8.5 Million | 51.9 Million | 66.7 Million | 53.5 Million | 30.8 Million | 41.03 Million |
| Change in working capital | -1.39 Billion | -1.03 Billion | -121.8 Million | 26.8 Million | -1.92 Billion | -1.2 Billion |
| Other non-cash items | 2.43 Billion | -1.26 Billion | -904.6 Million | -180.8 Million | -78.82 Million | -22.5 Million |
| Investing Cash Flow | -3.56 Billion | -2.17 Billion | -2.7 Billion | -53.59 Million | -545.04 Million | -1 Billion |
| Investments in PPE | -1.45 Billion | -1.93 Billion | -911.8 Million | -704.83 Million | -767.38 Million | -651.81 Million |
| Acquisitions | - | - | - | 212.4 Million | 91.06 Million | -102.8 Million |
| Investment purchases | -2.12 Billion | -1.41 Billion | -2 Billion | -212.4 Million | -2.25 Million | -198.58 Million |
| Sales/Maturities of investments | 24.1 Million | 921.8 Million | 9 Million | 451.97 Million | 98.83 Million | 18.05 Million |
| Other Investing Activities | -886.9 Million | 249.6 Million | 196 Million | 199.25 Million | 34.68 Million | -69.41 Million |
| Financing Cash Flow | -372.9 Million | -281.7 Million | -407.1 Million | -239.77 Million | 797.65 Million | 897.89 Million |
| Debt repayment | -31.3 Million | -29.1 Million | -165.6 Million | -194.11 Million | -2.15 Million | -351 Thousand |
| Dividends payments | -341.7 Million | -303.2 Million | -226.9 Million | -30.25 Million | -325.26 Million | -151.2 Million |
| Common Stock Repurchased | - | -29.1 Million | 165.6 Million | - | -2.24 Million | 351 Thousand |
| Common Stock Issuance | 100 Thousand | 200 Thousand | 300 Thousand | - | 25 Thousand | 54 Thousand |
| Other Financing Activities | -7.7 Million | 79.5 Million | -180.5 Million | -15.4 Million | 1.12 Billion | 1.04 Billion |
| Accounts receivables | -1.48 Billion | -770.1 Million | -407 Million | -835.33 Million | -2.16 Billion | -826.08 Million |
| Accounts payables | 767.5 Million | 318.3 Million | 837.7 Million | 835.33 Million | 312.44 Million | 826.08 Million |
| Inventory | -748.2 Million | -609 Million | -483.1 Million | 592.29 Million | -70.31 Million | -89.89 Million |
| Other working capital | 74.7 Million | 27.9 Million | -69.4 Million | -565.49 Million | 153.87 Million | -1.11 Billion |
| Cash at beginning of period | 1.79 Billion | 1.5 Billion | 4.35 Billion | 2.2 Billion | 1.5 Billion | 771.74 Million |
| Cash at end of period | 5.52 Billion | 1.77 Billion | 4.52 Billion | 4.52 Billion | 2.11 Billion | 1.5 Billion |
| Capital Expenditure | -1.45 Billion | -1.93 Billion | -911.8 Million | -704.83 Million | -767.38 Million | -651.81 Million |
| Effect of forex changes on cash | 8.6 Million | 11.8 Million | -900 Thousand | -2.38 Million | 1.74 Million | 7.21 Million |
| Net cash flow / Change in cash | 3.72 Billion | 268 Million | 167.8 Million | 2.31 Billion | 609.81 Million | 734.8 Million |
| Free Cash Flow | 2.15 Billion | 779 Million | 2.45 Billion | 1.95 Billion | -320.61 Million | 182.43 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.23 Billion | 1.21 Billion | 4.57 Billion | 1.17 Billion | 1.14 Billion | 1.03 Billion |
| Depreciation & Amortization | - | - | 534.4 Million | 139 Million | 117.6 Million | 113.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 8.5 Million | - | - | - |
| Change in working capital | - | - | -1.39 Billion | - | - | - |
| Other non-cash items | -1.23 Billion | -1.21 Billion | 2.43 Billion | -1.17 Billion | -1.14 Billion | -1.03 Billion |
| Investing Cash Flow | - | - | -3.56 Billion | - | - | - |
| Investments in PPE | - | - | -1.45 Billion | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -2.12 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 24.1 Million | - | - | - |
| Other Investing Activities | - | - | -886.9 Million | - | - | - |
| Financing Cash Flow | - | - | -372.9 Million | - | - | - |
| Debt repayment | - | - | -31.3 Million | - | - | - |
| Dividends payments | - | - | -341.7 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 100 Thousand | - | - | - |
| Other Financing Activities | - | - | -7.7 Million | - | - | - |
| Accounts receivables | - | - | -1.48 Billion | - | - | - |
| Accounts payables | - | - | 767.5 Million | - | - | - |
| Inventory | - | - | -748.2 Million | - | - | - |
| Other working capital | - | - | 74.7 Million | - | - | - |
| Cash at beginning of period | - | - | 1.79 Billion | 5.65 Billion | 5.42 Billion | 1.79 Billion |
| Cash at end of period | - | - | 5.52 Billion | 5.93 Billion | 5.65 Billion | 2.02 Billion |
| Capital Expenditure | - | - | -1.45 Billion | - | - | - |
| Effect of forex changes on cash | - | - | 8.6 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 3.72 Billion | 278 Million | 235.2 Million | 227.6 Million |
| Free Cash Flow | - | - | 2.15 Billion | 278 Million | 235.2 Million | 227.6 Million |
7679
SILLYMONKS
ARASE
FUIG
KDCE
THREL